CDC Works To Track Evidence Gaps On Pharmacogenetic Tests
This article was originally published in The Gray Sheet
Executive Summary
CMS is looking for the best ways to assess pharmacogenetic test data so it can keep its coverage policies current as new developments are made in personalized medicine